Xanthopoulos Kleanthis G Insider Trades

Insider Trading History

Track insider trading activity for Xanthopoulos Kleanthis G. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zosano Pharma
Zosano Pharma ZSAN
Director
Holding Value $13.2k 23,596 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$489k 15,000 shares
$32.61
$0.56
Zosano Pharma
Zosano Pharma ZSAN
Director
Holding Value $16.7k 30,000 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$978k 30,000 shares
$32.61
$0.56
Zosano Pharma
Zosano Pharma ZSAN
Director
Holding Value $4.79k 8,596 shares
Last Trade
Jun 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 7,500 shares
$29.34
$0.56
Zosano Pharma
Zosano Pharma ZSAN
Director
Holding Value $8.36k 15,000 shares
Last Trade
Jun 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$530k 15,000 shares
$35.35
$0.56
Zosano Pharma
Zosano Pharma ZSAN
Director
Holding Value $836 1,500 shares
Last Trade
Jan 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123k 1,500 shares
$81.90
$0.56
Zosano Pharma
Zosano Pharma ZSAN
Director
Holding Value $13.9k 25,000 shares
Last Trade
May 31, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.64M 25,000 shares
$145.60
$0.56
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $18.5k 50,000 shares
Last Trade
Jan 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2B 50,000 shares
$243,558.39
$0.37
Zosano Pharma
Zosano Pharma ZSAN
Director
Holding Value $16.7k 30,000 shares
Last Trade
Jan 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.1M 30,000 shares
$371.00
$0.56
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $9.09k 24,575 shares
Last Trade
Jan 05, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.22B 15,000 shares
$147,751.06
$0.37
Zosano Pharma
Zosano Pharma ZSAN
Director
Holding Value $11.2k 20,000 shares
Last Trade
Nov 02, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.05M 20,000 shares
$402.50
$0.56
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $35.4k 95,746 shares
Last Trade
Sep 30, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.64B 16,997 shares
$390,501.43
$0.37
Zosano Pharma
Zosano Pharma ZSAN
Director
Holding Value $8.88k 15,920 shares
Last Trade
Aug 19, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.9M 15,920 shares
$875.00
$0.56
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $29.1k 78,749 shares
Last Trade
Jun 30, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.64B 14,393 shares
$461,144.91
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $23.8k 64,356 shares
Last Trade
Apr 05, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.92B 8,621 shares
$686,811.57
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $18.5k 50,000 shares
Last Trade
Jan 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56B 50,000 shares
$1,119,676.00
$0.37
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $520k 63,705 shares
Last Trade
Apr 21, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$127M 60,000 shares
$2,114.40
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $67.6k 8,287 shares
Last Trade
Apr 21, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$127M 60,000 shares
$2,114.40
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $30.2k 3,705 shares
Last Trade
Apr 21, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$127M 60,000 shares
$2,114.40
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $557k 68,287 shares
Last Trade
Apr 20, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$136M 66,071 shares
$2,061.60
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President And CEO
Holding Value $569k 69,776 shares
Last Trade
Apr 20, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$136M 66,071 shares
$2,061.60
$8.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up